Received Aug 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC21 | PNEUMO (CAPVAXIVE) | MERCK & CO. INC. | UNK | — | RA |
On 7/29/25 he did not have a rash any longer, and today 7/30, it is back and stronger than it was and it is itching, at the same spot, around the inject site. Right arm.; On 7/29/25 he did not have a rash any longer, and today 7/30, it is back and stronger than it was and it is itching, at the same spot, around the inject site. Right arm.; Initially his arm was sore for a couple days; Headache; Fatigue; chills; slight rash around the injection site; a little swollen around injection site; This spontaneous report was received from a Consumer or other non health professional and refers to a 69-year-old male patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant medications included Rosuvastatin calcium (CRESTOR). On 25-Jul-2025, the patient was vaccinated with a dose of Pneumococcal 21-valent Conjugate Vaccine Injection (CAPVAXIVE) in Right Arm (strength, dose, dose number, route, lot # and expiration date were not reported) as vaccination. On 25-Jul-2025, the patient had initially his arm sore for a couple days (vaccination site pain) with chills, fatigue, headache, a little swollen (Vaccination site swelling) and a slight rash around the injection site ( Vaccination site rash). On 29-JUL-2025, the patient recovered from the vaccination site rash, however on 30-Jul-2025, the rash back and stronger (Vaccination site rash) than it was and it is itching at the same spot, around the inject site (Right arm) (Vaccination site pruritus). It was mentione that the patient did not Sought Medical Attention and not received treatment. At the reporting time, the patient had not recovered from Headache, vaccination site pain, Fatigue, chills, Vaccination site swelling, Vaccination site pruritus and Vaccination site rash (onset date: 30-Jul-2025). The causal relationship between all adverse events and Pneumococcal 21-valent Conjugate Vaccine Injection (CAPVAXIVE) was not provided.
CRESTOR